126 related articles for article (PubMed ID: 21398623)
1. A high-throughput fluorescence resonance energy transfer-based assay for DNA ligase.
Shapiro AB; Eakin AE; Walkup GK; Rivin O
J Biomol Screen; 2011 Jun; 16(5):486-93. PubMed ID: 21398623
[TBL] [Abstract][Full Text] [Related]
2. A high-throughput assay for the adenylation reaction of bacterial DNA ligase.
Miesel L; Kravec C; Xin AT; McMonagle P; Ma S; Pichardo J; Feld B; Barrabee E; Palermo R
Anal Biochem; 2007 Jul; 366(1):9-17. PubMed ID: 17493575
[TBL] [Abstract][Full Text] [Related]
3. Development of a fluorescence resonance energy transfer assay for measuring the activity of Streptococcus pneumoniae DNA ligase, an enzyme essential for DNA replication, repair, and recombination.
Chen XC; Hentz NG; Hubbard F; Meier TI; Sittampalam S; Zhao G
Anal Biochem; 2002 Oct; 309(2):232-40. PubMed ID: 12413456
[TBL] [Abstract][Full Text] [Related]
4. Complete steady-state rate equation for DNA ligase and its use for measuring product kinetic parameters of NAD⁺-dependent DNA ligase from Haemophilus influenzae.
Shapiro AB
BMC Res Notes; 2014 May; 7():287. PubMed ID: 24885075
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Optimization of NAD+-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds.
Bi F; Ma R; Ma S
Curr Pharm Des; 2017; 23(14):2117-2130. PubMed ID: 27784238
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of an inhibitor specific to bacterial NAD+-dependent DNA ligases.
Meier TI; Yan D; Peery RB; McAllister KA; Zook C; Peng SB; Zhao G
FEBS J; 2008 Nov; 275(21):5258-71. PubMed ID: 18795946
[TBL] [Abstract][Full Text] [Related]
7. A homogeneous, high-throughput fluorescence resonance energy transfer-based DNA polymerase assay.
Shapiro A; Rivin O; Gao N; Hajec L
Anal Biochem; 2005 Dec; 347(2):254-61. PubMed ID: 16266678
[TBL] [Abstract][Full Text] [Related]
8. NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: novel structure-function relationship and identification of a specific inhibitor.
Srivastava SK; Dube D; Kukshal V; Jha AK; Hajela K; Ramachandran R
Proteins; 2007 Oct; 69(1):97-111. PubMed ID: 17557328
[TBL] [Abstract][Full Text] [Related]
9. The kinetic mechanism of S. pneumoniae DNA ligase and inhibition by adenosine-based antibacterial compounds.
Jahić H; Liu CF; Thresher J; Livchak S; Wang H; Ehmann DE
Biochem Pharmacol; 2012 Sep; 84(5):654-60. PubMed ID: 22743594
[TBL] [Abstract][Full Text] [Related]
10. Discovery of bacterial NAD+-dependent DNA ligase inhibitors: optimization of antibacterial activity.
Stokes SS; Huynh H; Gowravaram M; Albert R; Cavero-Tomas M; Chen B; Harang J; Loch JT; Lu M; Mullen GB; Zhao S; Liu CF; Mills SD
Bioorg Med Chem Lett; 2011 Aug; 21(15):4556-60. PubMed ID: 21719282
[TBL] [Abstract][Full Text] [Related]
11. Bacterial DNA replication enzymes as targets for antibacterial drug discovery.
Sanyal G; Doig P
Expert Opin Drug Discov; 2012 Apr; 7(4):327-39. PubMed ID: 22458504
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor assay based on fluorescence resonance energy transfer.
Riester D; Hildmann C; Schwienhorst A; Meyer-Almes FJ
Anal Biochem; 2007 Mar; 362(1):136-41. PubMed ID: 17250798
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput continuous assay for screening and characterization of inhibitors of HIV reverse-transcriptase DNA polymerase activity.
Cauchon E; Falgueyret JP; Auger A; Melnyk RA
J Biomol Screen; 2011 Jun; 16(5):518-24. PubMed ID: 21474837
[TBL] [Abstract][Full Text] [Related]
14. Structure guided understanding of NAD+ recognition in bacterial DNA ligases.
Lahiri SD; Gu RF; Gao N; Karantzeni I; Walkup GK; Mills SD
ACS Chem Biol; 2012 Mar; 7(3):571-80. PubMed ID: 22230472
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I.
Srivastava SK; Dube D; Tewari N; Dwivedi N; Tripathi RP; Ramachandran R
Nucleic Acids Res; 2005; 33(22):7090-101. PubMed ID: 16361267
[TBL] [Abstract][Full Text] [Related]
16. NAD(+)-dependent DNA ligase: a novel target waiting for the right inhibitor.
Dwivedi N; Dube D; Pandey J; Singh B; Kukshal V; Ramachandran R; Tripathi RP
Med Res Rev; 2008 Jul; 28(4):545-68. PubMed ID: 18080330
[TBL] [Abstract][Full Text] [Related]
17. A high-throughput, homogeneous, fluorescence resonance energy transfer-based assay for phospho-N-acetylmuramoyl-pentapeptide translocase (MraY).
Shapiro AB; Jahić H; Gao N; Hajec L; Rivin O
J Biomol Screen; 2012 Jun; 17(5):662-72. PubMed ID: 22337656
[TBL] [Abstract][Full Text] [Related]
18. Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo.
Mills SD; Eakin AE; Buurman ET; Newman JV; Gao N; Huynh H; Johnson KD; Lahiri S; Shapiro AB; Walkup GK; Yang W; Stokes SS
Antimicrob Agents Chemother; 2011 Mar; 55(3):1088-96. PubMed ID: 21189350
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore-based screening and identification of novel human ligase I inhibitors with potential anticancer activity.
Krishna S; Singh DK; Meena S; Datta D; Siddiqi MI; Banerjee D
J Chem Inf Model; 2014 Mar; 54(3):781-92. PubMed ID: 24593844
[TBL] [Abstract][Full Text] [Related]
20. Negishi cross-coupling enabled synthesis of novel NAD(+)-dependent DNA ligase inhibitors and SAR development.
Murphy-Benenato KE; Gingipalli L; Boriack-Sjodin PA; Martinez-Botella G; Carcanague D; Eyermann CJ; Gowravaram M; Harang J; Hale MR; Ioannidis G; Jahic H; Johnstone M; Kutschke A; Laganas VA; Loch JT; Miller MD; Oguto H; Patel SJ
Bioorg Med Chem Lett; 2015 Nov; 25(22):5172-7. PubMed ID: 26463129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
